» Articles » PMID: 34073504

A Well-Structured Follow-Up Program is Required After Recovery from Coronavirus Disease 2019 (COVID-19); Release from Quarantine is Not the End of Treatment

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jun 2
PMID 34073504
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

During the Coronavirus Infection Disease-19 (COVID-19) pandemic, the number of patients released from quarantine is exceeding the number of newly diagnosed cases. This study is a retrospective cohort study in which consultation data were collected from a COVID-19 follow-up health consultation program. The studied population was selected from patients who recovered after quarantine and treatment for COVID-19 in Daegu City and in Gyeongsangbukdo province, Korea, from March to June 2020. The healthcare providers comprised 20 family-medicine specialists who consulted and educated the patients through phone calls in accordance with structured guidelines. Physical and mental status before and after recovery were compared among patients who received a single consultation and those who received two or more consultations. A total of 1604 subjects were selected for the final analysis. Of these, 1145 (71.4%) had one consultation and 459 (28.6%) had two or more. The group that had two or more consultations reported significantly more physical symptoms, more psychological symptoms (including depression), and more psychological stress. Multivariate forward selection logistic regression analysis showed that re-confirmed cases of COVID-19, physical symptoms after quarantine, feelings of depression, and psychological stress had a significant effect on the number of consultations received. In conclusion, COVID-19 has various physical and mental sequelae after discharge from quarantine. Therefore, a well-structured follow-up program is needed after recovery.

Citing Articles

Post-COVID Quality of Life and Sleep Among Younger Healthcare Workers of Designated COVID Care Centers: A Cross-Sectional Study.

Ts P, Kk A, Bhavanam S, Mathew B Cureus. 2023; 15(4):e38190.

PMID: 37252472 PMC: 10222835. DOI: 10.7759/cureus.38190.


Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review.

Chandan J, Brown K, Simms-Williams N, Bashir N, Camaradou J, Heining D Int J Environ Res Public Health. 2023; 20(4).

PMID: 36834176 PMC: 9967466. DOI: 10.3390/ijerph20043477.


Evaluation of a Follow-Up Health Consultation Program for Patients with Coronavirus Disease 2019 in Korea: Using the Context-Input-Process-Product Model.

Lee K, Ko H, Lee G, Kim Y, Jung S, Kim A Int J Environ Res Public Health. 2022; 19(13).

PMID: 35805654 PMC: 9266060. DOI: 10.3390/ijerph19137996.


The New COVID-19 Related Psychological Distress Pandemic.

Roccella M, Lavanco G, Vetri L J Clin Med. 2022; 11(1).

PMID: 35011978 PMC: 8745915. DOI: 10.3390/jcm11010237.

References
1.
Shi F, Wu T, Zhu X, Ge Y, Zeng X, Chi Y . Association of viral load with serum biomakers among COVID-19 cases. Virology. 2020; 546:122-126. PMC: 7192122. DOI: 10.1016/j.virol.2020.04.011. View

2.
Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View

3.
Oran D, Topol E . Prevalence of Asymptomatic SARS-CoV-2 Infection : A Narrative Review. Ann Intern Med. 2020; 173(5):362-367. PMC: 7281624. DOI: 10.7326/M20-3012. View

4.
Ohtake P, Lee A, Scott J, Hinman R, Ali N, Hinkson C . Physical Impairments Associated With Post-Intensive Care Syndrome: Systematic Review Based on the World Health Organization's International Classification of Functioning, Disability and Health Framework. Phys Ther. 2018; 98(8):631-645. DOI: 10.1093/ptj/pzy059. View

5.
To K, Hung I, Ip J, Chu A, Chan W, Tam A . Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing. Clin Infect Dis. 2020; 73(9):e2946-e2951. PMC: 7499500. DOI: 10.1093/cid/ciaa1275. View